C93H120Cl2N20O14S4 — CID 161040261
(3R)-4-[2-(2-chloro-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-chloro-6-methyl-4-pyridinyl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-ethoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-methoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine (PubChem CID 161040261) has the molecular formula C93H120Cl2N20O14S4 and a molecular weight of 1941.28 g/mol. Its IUPAC name is (3R)-4-[2-(2-chloro-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-chloro-6-methyl-4-pyridinyl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-ethoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-methoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine.
| Compound Name | (3R)-4-[2-(2-chloro-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-chloro-6-methyl-4-pyridinyl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-ethoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-methoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine |
|---|---|
| PubChem CID | 161040261 |
| Molecular Formula | C93H120Cl2N20O14S4 |
| Molecular Weight | 1941.28 g/mol |
| Exact Mass | 1938.76 |
| IUPAC Name | (3R)-4-[2-(2-chloro-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-chloro-6-methyl-4-pyridinyl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-ethoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[2-(2-methoxy-7H-cyclopenta[b]pyridin-4-yl)-6-(1-methylsulfonylpiperidin-4-yl)pyrimidin-4-yl]-3-methylmorpholine |
| SMILES | CCOc1cc(-c2nc(C3CCN(S(C)(=O)=O)CC3)cc(N3CCOC[C@H]3C)n2)c2c(n1)CC=C2.COc1cc(-c2nc(C3CCN(S(C)(=O)=O)CC3)cc(N3CCOC[C@H]3C)n2)c2c(n1)CC=C2.C[C@@H]1COCCN1c1cc(C2CCN(S(C)(=O)=O)CC2)nc(-c2cc(Cl)nc3c2C=CC3)n1.Cc1cc(-c2nc(C3CCN(S(C)(=O)=O)CC3)cc(N3CCOC[C@H]3C)n2)cc(Cl)n1 |
| InChI | InChI=1S/C25H33N5O4S.C24H31N5O4S.C23H28ClN5O3S.C21H28ClN5O3S/c1-4-34-24-14-20(19-6-5-7-21(19)26-24)25-27-22(18-8-10-29(11-9-18)35(3,31)32)15-23(28-25)30-12-13-33-16-17(30)2;1-16-15-33-12-11-29(16)22-14-21(17-7-9-28(10-8-17)34(3,30)31)26-24(27-22)19-13-23(32-2)25-20-6-4-5-18(19)20;1-15-14-32-11-10-29(15)22-13-20(16-6-8-28(9-7-16)33(2,30)31)26-23(27-22)18-12-21(24)25-19-5-3-4-17(18)19;1-14-10-17(11-19(22)23-14)21-24-18(16-4-6-26(7-5-16)31(3,28)29)12-20(25-21)27-8-9-30-13-15(27)2/h5-6,14-15,17-18H,4,7-13,16H2,1-3H3;4-5,13-14,16-17H,6-12,15H2,1-3H3;3-4,12-13,15-16H,5-11,14H2,1-2H3;10-12,15-16H,4-9,13H2,1-3H3/t17-;16-;2*15-/m1111/s1 |
| InChIKey | UAUDKEDWZKHQIA-JQZZDUNXSA-N |
| XLogP | 11.34 |
| TPSA | 372.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 133 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1941.28 |
| LogP ≤ 5 | 11.34 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|